AJ
AGN

Ashburton (Jersey)’s Allergan plc AGN Stock Holding History

Ashburton (Jersey)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-195,504
Closed -$15.1M – 92
2020
Q3 		$15.1M Hold
195,504
– – 7.8% 6
2020
Q2 		$15.1M Buy
195,504
+194,008
+12,968% +$36M 7.8% 6
2020
Q1 		$58K Hold
1,496
– – 0.03% 47
2019
Q4 		$75K Buy
+1,496
New +$270K 0.03% 49
2019
Q3 		– Sell
-1,553
Closed -$74K – 110
2019
Q2 		$74K Sell
1,553
-165,835
-99% -$23M 0.04% 50
2019
Q1 		$4.21M Buy
167,388
+152,070
+993% +$22M 2.14% 12
2018
Q4 		$29.9M Buy
+15,318
New +$2.51M 14.1% 1
2018
Q3 		– Sell
-72,971
Closed -$981K – 79
2018
Q2 		$981K Buy
+72,971
New +$11.7M 0.42% 28
2018
Q1 		– Sell
-170,220
Closed -$1.43M – 87
2017
Q4 		$1.43M Buy
170,220
+152,629
+868% +$27.4M 0.57% 32
2017
Q3 		$5.81M Buy
+17,591
New +$4.09M 2.55% 11
2017
Q1 		– Sell
-2,524
Closed -$530K – 79
2016
Q4 		$530K Hold
2,524
– – 0.23% 71
2016
Q3 		$581K Buy
+2,524
New +$617K 0.27% 73

Other funds holding AGN

CIC
Cornercap Investment Counsel Atlanta, Georgia $203M AUM 17.67% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Ashburton (Jersey)'s AGN Position: Q4 2020 in Review

Ashburton (Jersey) sold out of Allergan plc (AGN) in Q4 2020, closing a stake of 195,504 shares — an estimated $15.1M sold.

Ashburton (Jersey) first reported a position in AGN in Q3 2016 and held it in 12 quarters. The position peaked at $29.9M in Q4 2018. 3 funds tracked by Wall St. Rank hold AGN as of Q4 2020.

  • Ashburton (Jersey) reported no remaining Allergan plc position as of Q4 2020 after selling out during the quarter.
  • Ashburton (Jersey) sold 195,504 Allergan plc shares in Q4 2020, an estimated $15.1M.
  • Ashburton (Jersey) first reported a position in Allergan plc in Q3 2016 and held it in 12 quarters.
  • Ashburton (Jersey)'s Allergan plc position peaked at $29.9M in Q4 2018.
  • 3 funds tracked by Wall St. Rank held Allergan plc as of Q4 2020.

Based on Ashburton (Jersey)'s 13F filing for Q4 2020, filed 23 May 2023.